Plain-English translation of NCT05732155 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Post Traumatic Stress Disorder research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether MDMA—a medication that may help people process difficult emotions—combined with professional therapy can reduce symptoms of PTSD and moral injury in Israeli veterans from special forces units. Participants will receive the medication during three monthly sessions with a therapist, followed by additional therapy sessions to help them integrate what they've learned. The study wants to see if this approach is safe and whether it helps veterans feel better.
Many veterans experience deep psychological wounds that don't respond well to standard treatments alone. This medication may help people access and process traumatic memories more safely during therapy, potentially offering relief when other approaches haven't fully worked.
You likely qualify if…
You likely don't qualify if…
You would attend about 3 preparation sessions before starting treatment, then receive the medication during 3 monthly therapy sessions (2 individual and 1 group), with overnight stays at the study site after each medication session. Between these main sessions, you'll have additional therapy visits to process your experience. The entire study takes about 35 weeks, with regular check-ins to measure how you're doing using standardized questionnaires.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Israel